Paper33799992
The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis.
Moretti A and 7 others. Int J Mol Sci, 2021. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. The Rationale for the Intra-Articular Administration of Clodronate in Osteoarthritis. Papers, record 33799992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33799992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clodronic Acid | Major topic |
| Osteoarthritis | Major topic |
| Animals | |
| Disease Models, Animal | |
| Humans | |
| Injections, Intra-Articular | |
| Mice | |
| Rabbits |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32543240 | The perspectives of intra-articular therapy in the management of osteoarthritis. | Expert Opin Drug Deliv | 2020 | https://conductscience.org/library/papers/32543240 | PubMed |
| 2 | 2994231 | The synovial lining cell: biology and pathobiology. | Semin Arthritis Rheum | 1985 | https://conductscience.org/library/papers/2994231 | PubMed |
| 3 | 7992110 | Osteoarthritis of the knee: correlation of subchondral MR signal abnormalities with histopathologic and radiographic features. | Skeletal Radiol | 1994 | https://conductscience.org/library/papers/7992110 | PubMed |
| 4 | 19406908 | Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. | Rheumatology (Oxford) | 2009 | https://conductscience.org/library/papers/19406908 | PubMed |
| 5 | 17195217 | Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. | Arthritis Rheum | 2007 | https://conductscience.org/library/papers/17195217 | PubMed |
| 6 | 15262242 | Synovial lining macrophages mediate osteophyte formation during experimental osteoarthritis. | Osteoarthritis Cartilage | 2004 | https://conductscience.org/library/papers/15262242 | PubMed |
| 7 | 8516620 | Reversible depletion of synovial lining cells after intra-articular treatment with liposome-encapsulated dichloromethylene diphosphonate. | Rheumatol Int | 1993 | https://conductscience.org/library/papers/8516620 | PubMed |
| 8 | 27233775 | Bone marrow lesions in hip osteoarthritis are characterized by increased bone turnover and enhanced angiogenesis. | Osteoarthritis Cartilage | 2016 | https://conductscience.org/library/papers/27233775 | PubMed |
| 9 | 9876398 | Increased secretion and activity of matrix metalloproteinase-3 in synovial tissues and chondrocytes from experimental osteoarthritis. | Osteoarthritis Cartilage | 1998 | https://conductscience.org/library/papers/9876398 | PubMed |
| 10 | 11592386 | The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis. | Arthritis Rheum | 2001 | https://conductscience.org/library/papers/11592386 | PubMed |
| 11 | 25987988 | Acidic microenvironment and bone pain in cancer-colonized bone. | Bonekey Rep | 2015 | https://conductscience.org/library/papers/25987988 | PubMed |
| 12 | 8214013 | In vivo role of phagocytic synovial lining cells in onset of experimental arthritis. | Am J Pathol | 1993 | https://conductscience.org/library/papers/8214013 | PubMed |
| 13 | 29947493 | Clodronate in the management of different musculoskeletal conditions. | Minerva Med | 2018 | https://conductscience.org/library/papers/29947493 | PubMed |
| 14 | 16769263 | Osteoclasts play a part in pain due to the inflammation adjacent to bone. | Bone | 2006 | https://conductscience.org/library/papers/16769263 | PubMed |
| 15 | 23326188 | Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. | Drug Des Devel Ther | 2013 | https://conductscience.org/library/papers/23326188 | PubMed |
| 16 | 12713267 | Expression of bone morphogenetic proteins and cartilage-derived morphogenetic proteins during osteophyte formation in humans. | J Anat | 2003 | https://conductscience.org/library/papers/12713267 | PubMed |
| 17 | 31278997 | OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. | Osteoarthritis Cartilage | 2019 | https://conductscience.org/library/papers/31278997 | PubMed |
| 18 | 29146440 | Clodronate: A Vesicular ATP Release Blocker. | Trends Pharmacol Sci | 2018 | https://conductscience.org/library/papers/29146440 | PubMed |
| 19 | 10210733 | Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite. | Eur J Pharm Sci | 1999 | https://conductscience.org/library/papers/10210733 | PubMed |
| 20 | 31347149 | Pharmacology of bisphosphonates in pain. | Br J Pharmacol | 2021 | https://conductscience.org/library/papers/31347149 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42377751 | Osthole attenuates cartilage degradation and chondrocyte pyroptosis in knee osteoarthritis and is associated with activation of the PI3K/Akt pathway. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42377751 | PubMed |
| 41836180 | Influence of Synovial Fluid Biochemical Markers on Clinical Outcomes Following Arthroscopic and Non-Arthroscopic Patients with Knee Osteoarthritis. | Orthop Rev (Pavia) | 2026 | https://conductscience.org/library/papers/41836180 | PubMed |
| 41376619 | Mechanisms of synovial macrophage polarization in osteoarthritis pathogenesis and their therapeutic implications. | Front Immunol | 2025 | https://conductscience.org/library/papers/41376619 | PubMed |
| 39957690 | Proteases and Osteoporosis: A Comprehensive Review of Their Role in Bone Health. | Curr Drug Targets | 2025 | https://conductscience.org/library/papers/39957690 | PubMed |
| 39889821 | Advances in the pathology and treatment of osteoarthritis. | J Adv Res | 2025 | https://conductscience.org/library/papers/39889821 | PubMed |
| 39188952 | Osteoporosis treatment: current drugs and future developments. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39188952 | PubMed |
| 38785519 | Osteoarthritis: Insights into Diagnosis, Pathophysiology, Therapeutic Avenues, and the Potential of Natural Extracts. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/38785519 | PubMed |
| 36830637 | Metalloproteases in Pain Generation and Persistence: A Possible Target? | Biomolecules | 2023 | https://conductscience.org/library/papers/36830637 | PubMed |
| 36443838 | Intra-articular injection choice for osteoarthritis: making sense of cell source-an updated systematic review and dual network meta-analysis. | Arthritis Res Ther | 2022 | https://conductscience.org/library/papers/36443838 | PubMed |
| 36337155 | Therapeutic applications of adipose-derived stromal vascular fractions in osteoarthritis. | World J Stem Cells | 2022 | https://conductscience.org/library/papers/36337155 | PubMed |
| 35619876 | Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). | Ther Adv Musculoskelet Dis | 2022 | https://conductscience.org/library/papers/35619876 | PubMed |
| 34262259 | The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date. | Drug Des Devel Ther | 2021 | https://conductscience.org/library/papers/34262259 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BMP2 | 650 | PubTator's text mining | https://conductscience.org/library/genes/650 | NCBI Gene |
| BMP4 | 652 | PubTator's text mining | https://conductscience.org/library/genes/652 | NCBI Gene |
| IL1A | 3552 | PubTator's text mining | https://conductscience.org/library/genes/3552 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP3 | 4314 | PubTator's text mining | https://conductscience.org/library/genes/4314 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TRPV1 | 7442 | PubTator's text mining | https://conductscience.org/library/genes/7442 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33799992
GET https://conductscience.org/api/papers/v1/33799992/references?page=2